Photo by robertbye from unsplash
In this issue of Cancer Cell, Newell et al. introduce whole-genome and methylome data to melanoma immunotherapy response analysis. Genome breaks are more frequent in resistant tumors, but the best response… Click to show full abstract
In this issue of Cancer Cell, Newell et al. introduce whole-genome and methylome data to melanoma immunotherapy response analysis. Genome breaks are more frequent in resistant tumors, but the best response classifiers remain mutation burden and interferon-ɣ signature. Clinical translation will need aggregation of many such datasets.
Keywords:
immunotherapy new;
multi omics;
melanoma immunotherapy;
melanoma;
omics prediction;
prediction melanoma
Journal Title: Cancer cell
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Cancer cell
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!